tiprankstipranks
Trending News
More News >
Dedicare AB (SE:DEDI)
:DEDI
Sweden Market
Advertisement

Dedicare AB (DEDI) AI Stock Analysis

Compare
0 Followers

Top Page

SE:DEDI

Dedicare AB

(DEDI)

Select Model
Select Model
Select Model
Outperform 75 (OpenAI - 4o)
Rating:75Outperform
Price Target:
kr52.00
▲(12.80% Upside)
Dedicare AB's strong financial performance and attractive valuation are the primary drivers of its overall score. While technical indicators present a mixed picture, the company's solid financial foundation and appealing dividend yield make it a compelling investment opportunity.

Dedicare AB (DEDI) vs. iShares MSCI Sweden ETF (EWD)

Dedicare AB Business Overview & Revenue Model

Company DescriptionDedicare AB (DEDI) is a Swedish staffing and recruitment company specializing in the healthcare sector. The company primarily focuses on providing qualified personnel, including nurses, doctors, and other healthcare professionals, to hospitals and care facilities across Sweden and Norway. With a commitment to quality and reliability, Dedicare aims to meet the growing demands of the healthcare industry by offering flexible staffing solutions tailored to the specific needs of its clients.
How the Company Makes MoneyDedicare AB generates revenue through its staffing services, which include temporary and permanent placement of healthcare professionals. The company charges its clients a fee based on the hourly rates of the personnel provided, along with additional charges for recruitment and administrative services. Key revenue streams include contracts with hospitals, nursing homes, and private care providers, where they supply staff on an as-needed basis. Dedicare may also engage in partnerships with healthcare institutions to secure long-term contracts, thereby ensuring a steady flow of income. Factors contributing to its earnings include the increasing demand for healthcare services, regulatory changes affecting staffing requirements, and the company's reputation for delivering high-quality professionals in a competitive market.

Dedicare AB Financial Statement Overview

Summary
Dedicare AB displays a strong financial profile with robust cash flow, stable growth, and a secure balance sheet. Despite recent pressures on revenue and net income, the company's solid margins and low leverage position it well for future resilience.
Income Statement
75
Positive
The company has shown consistent revenue growth over the years, although there was a decline in 2024. Gross profit margins have been relatively stable, indicating efficient cost management. Net profit margin decreased in 2024, reflecting some challenges in maintaining profitability levels. The EBIT and EBITDA margins have been solid, pointing to strong operational performance.
Balance Sheet
80
Positive
Dedicare AB maintains a strong equity position with a healthy equity ratio, indicating financial stability. The debt-to-equity ratio is low, suggesting prudent financial management and low leverage risk. Return on equity remains attractive, showcasing effective use of shareholder funds.
Cash Flow
78
Positive
Operating cash flow remains robust and consistently exceeds net income, demonstrating strong cash generation. Free cash flow growth has been positive, although it decreased in the latest period. The ratios of operating and free cash flow to net income indicate efficient cash management relative to earnings.
BreakdownTTMDec 2024Dec 2023Dec 2022Dec 2021Dec 2020
Income Statement
Total Revenue1.55B1.72B1.97B1.77B1.25B885.20M
Gross Profit237.30M444.92M351.50M529.42M337.40M125.52M
EBITDA69.70M89.34M171.42M154.37M102.31M61.38M
Net Income37.30M47.07M110.40M101.30M65.56M36.06M
Balance Sheet
Total Assets568.00M628.76M727.32M742.68M497.86M384.61M
Cash, Cash Equivalents and Short-Term Investments95.00M115.26M187.15M142.80M132.43M100.29M
Total Debt22.30M38.05M87.96M116.01M33.55M40.92M
Total Liabilities285.40M329.46M417.39M480.13M319.37M249.19M
Stockholders Equity282.60M299.30M309.93M262.56M178.49M135.42M
Cash Flow
Free Cash Flow63.00M78.03M140.85M99.97M67.30M37.54M
Operating Cash Flow64.60M81.28M145.40M105.34M69.59M40.10M
Investing Cash Flow-37.80M-39.47M-9.67M-68.61M-2.29M-26.47M
Financing Cash Flow-57.90M-88.19M-81.83M-30.07M-36.74M25.80M

Dedicare AB Technical Analysis

Technical Analysis Sentiment
Neutral
Last Price46.10
Price Trends
50DMA
45.80
Positive
100DMA
45.63
Positive
200DMA
47.04
Negative
Market Momentum
MACD
-0.03
Negative
RSI
52.08
Neutral
STOCH
83.33
Negative
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For SE:DEDI, the sentiment is Neutral. The current price of 46.1 is above the 20-day moving average (MA) of 45.58, above the 50-day MA of 45.80, and below the 200-day MA of 47.04, indicating a neutral trend. The MACD of -0.03 indicates Negative momentum. The RSI at 52.08 is Neutral, neither overbought nor oversold. The STOCH value of 83.33 is Negative, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Neutral sentiment for SE:DEDI.

Dedicare AB Peers Comparison

Overall Rating
UnderperformOutperform
Sector (51)
Financial Indicators
Name
Overall Rating
Market Cap
P/E Ratio
ROE
Dividend Yield
Revenue Growth
EPS Growth
75
Outperform
kr438.45M11.725.46%-16.43%-57.84%
51
Neutral
$7.86B-0.30-43.30%2.27%22.53%-2.21%
47
Neutral
€281.35M-32.63%4.53%-19.81%-203.10%
46
Neutral
€104.58M-31.59%-21.52%-26.42%
46
Neutral
kr27.85M-1.79%11.43%-18.08%-206.17%
* Healthcare Sector Average
Performance Comparison
Ticker
Company Name
Price
Change
% Change
SE:DEDI
Dedicare AB
45.80
-18.03
-28.25%
SE:WISE
Wise Group AB
13.55
-4.70
-25.75%
SE:PION.B
Poolia AB Class B
5.88
-0.38
-6.07%
SE:HEGR
Hedera Group AB
0.79
-2.30
-74.51%
SE:NGS
NGS Group AB
2.90
-0.34
-10.49%
SE:NJOB
NetJobs Group AB
0.84
0.55
189.66%
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: Oct 16, 2025